Three Months Ended September 30, 2024

Number of Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term (in Years)

Aggregate Intrinsic Value

Stock options:

(In Thousands)

Non-vested at beginning of period

166,096

$

8.06

8.9

$

234

     Granted

—

—

—

—

     Vested

—

—

—

—

 Forfeited

—

—

—

—

Non-vested at end of period

166,096

$

8.06

8.7

$

252

Nine Months Ended September 30, 2024

Number of Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term (in Years)

Aggregate Intrinsic Value

Stock options:

(In Thousands)

Non-vested at beginning of period

249,144

$

8.06

9.4

$

—

     Granted

—

—

—

—

     Vested

(83,048

)

8.06

—

—

 Forfeited

—

—

—

—

Non-vested at end of period

166,096

$

8.06

8.7

$

252

Year Ended December 31, 2023

Number of Shares

Weighted Average Exercise Price

Weighted Average Remaining Contractual Term (in Years)

Aggregate Intrinsic Value

Stock options:

(In Thousands)

Non-vested at beginning of period

—

$

—

—

$

—

     Granted

249,144

8.06

9.4

—

     Vested

—

—

—

—

 Forfeited

—

—

—

—

Non-vested at end of period

249,144

$

8.06

9.4

$

—

Date of grant

5/25/2023

    Options granted

249,144

Exercise price

$

8.06

Vesting period(1)

3 years

Expiration date

5/25/2033

Expected volatility

27.8

%

Expected term

6.5 years

    Expected dividend yield

0

%

    Expected forfeiture rate

0

%

    Risk free interest rate

3.9

%

Fair value per option

$

3.00

(1) Vesting is ratably and the period begins on the date of the grant.